Adrenalinum
Adrenalinum is an FDA drug label for the active ingredient EPINEPHRINE manufactured by Boiron administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231221.
Generic: EPINEPHRINE
Manufacturer: Boiron
Product Type: HUMAN OTC DRUG
Route: ORAL
Dosage Form:
NDC: 0220-0076
Application:
Effective: 20231221
Active Ingredients: Adrenalinum 30C (**contains 0.443 mg of the active ingredient per pellet) Less than 10 -12 mg adrenalin per pellet
Indications & Usage
Rx Only*
Dosage & Administration
Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
Contraindications
Not available.
Warnings
Not available.
Adverse Reactions
Not available.
More from same ingredient
Adrenalin
Medical Purchasing Solutions, LLC
Auvi-Q
Medical Purchasing Solutions, LLC
Auvi-Q
Medical Purchasing Solutions, LLC
EPINEPHRINE
HF Acquisition Co LLC, DBA HealthFirst
EPINEPHRINE
HF Acquisition Co LLC, DBA HealthFirst
EPINEPHRINE
Medical Purchasing Solutions, LLC